Our vision is to help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research the disease. About Job Syndrome Scientific Advisory Board Apply for grant funding Job Research Foundation Announces 2026 Grant Recipient Job Research Foundation Announces 9th Round of Funding for Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder Worldwide BMT experience of Job Syndrome published in Blood Advances Job Research Foundation Announces 2025 Grant Recipient Job Research Foundation Announces 7th Round of Funding:Up to $400,000 in Grants Available to Researchers Investigating Causes/Treatments of RareMultisystem Immunodeficiency Disorder Job Research Foundation Announces 2024 Grant Recipient Job Research Foundation Announces 6th Round of Funding: Up to $400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder Job Research Foundation 5 Year Summary Job Research Foundation Announces 2023 Grant RecipientsFoundation Marks Five Year Milestone Investigating Health Status and Quality of Life in Patients with STAT3-DN-HIES Job Research Foundation Announces 2022 Grant Recipients Job Research Foundation Announces 2021 Grant Recipients; Funding will Support Research into the Causes of and Treatments for Job Syndrome Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome - Journal of Clinical Immunology Skin infections turned out to be sign of serious problem for little girl - The Washington Post Job Research Foundation Announces the Appointment of Dr. Joshua Milner, Director of Allergy/Immunology and Rheumatology at Columbia University Irving Medical Center, to its Scientific Advisory Board